Center for Oral Health Research, College of Dentistry, University of Kentucky, Lexington, KY 40503, United States.
Arch Oral Biol. 2011 Jul;56(7):650-4. doi: 10.1016/j.archoralbio.2011.01.011. Epub 2011 Feb 17.
This study assessed the antibacterial activity of short-, medium-, and long-chain fatty acids against various oral microorganisms.
The short-chain fatty acids [formic acid (C1), acetic acid (C2), propionic acid (C3), butyric acid (C4), isobutyric acid (C4), isovaleric acid (C5), hexanoic acid (C6)], medium-chain fatty acids [octanoic acid (C8), capric acid (C10), lauric acid (12)], and long-chain fatty acids [myristic acid (C14), palmitic acid (C16)], were investigated for antimicrobial activity against Streptococcus mutans, Streptococcus gordonii, Streptococcus sanguis, Candida albicans, Aggregatibacter actinomycetemcomitans, Fusobacterium nucleatum, and Porphyromonas gingivalis.
The data demonstrated that the fatty acids exhibited patterns of inhibition against oral bacteria with some specificity that appeared related more to the bacterial species that the general structural characteristics of the microorganism. As a group the fatty acids were much less effective against C. albicans than the oral bacteria, with effectiveness limited to hexanoic, octanoic, and lauric acids. Formic acid, capric, and lauric acids were broadly inhibitory for the bacteria. Interestingly, fatty acids that are produced at metabolic end-products by a number of these bacteria, were specifically inactive against the producing species, whilst substantially inhibiting the growth of other oral microorganisms.
The results indicate that the antimicrobial activity of short-chain fatty acids (SCFAs), medium-chain fatty acids (MCFAs), long-chain fatty acids (LCFAs) could influence the microbial ecology in the oral cavity via at least 2 potential pathways. First, the agents delivered exogenously as therapeutic adjuncts could be packaged to enhance a microbial-regulatory environment in the subgingival sulcus. Second, it would be the intrinsic nature of these fatty acid inhibitors in contributing to the characteristics of the microbial biofilms, their evolution, and emergence of species within the biofilms. Further studies on these functions are required to better understand the nature of these potential microbial interactions in the biofilms.
本研究评估了短链、中链和长链脂肪酸对各种口腔微生物的抗菌活性。
短链脂肪酸(甲酸(C1)、乙酸(C2)、丙酸(C3)、丁酸(C4)、异丁酸(C4)、异戊酸(C5)、己酸(C6))、中链脂肪酸(辛酸(C8)、癸酸(C10)、月桂酸(12))和长链脂肪酸(肉豆蔻酸(C14)、棕榈酸(C16))被研究了对变形链球菌、戈登链球菌、血链球菌、白色念珠菌、伴放线放线杆菌、核梭杆菌和牙龈卟啉单胞菌的抗菌活性。
数据表明,脂肪酸对口腔细菌的抑制模式具有一定的特异性,这种特异性似乎与细菌的种类更相关,而不是与微生物的一般结构特征相关。作为一个整体,脂肪酸对白色念珠菌的有效性远低于口腔细菌,其有效性仅限于己酸、辛酸和月桂酸。甲酸、癸酸和月桂酸对细菌具有广泛的抑制作用。有趣的是,许多细菌在代谢终产物中产生的脂肪酸,对产生的细菌特异性地没有活性,而对其他口腔微生物的生长有很大的抑制作用。
结果表明,短链脂肪酸(SCFAs)、中链脂肪酸(MCFAs)、长链脂肪酸(LCFAs)的抗菌活性可能通过至少 2 种潜在途径影响口腔微生物区系。首先,作为治疗辅助剂外源性给予的药物可以被包装,以增强龈下沟中的微生物调节环境。其次,这些脂肪酸抑制剂的内在性质可能有助于微生物生物膜的特性、其进化以及生物膜内物种的出现。需要进一步研究这些功能,以更好地了解这些潜在微生物相互作用在生物膜中的性质。